4-(Methylmercapto)phenol is used as a reagent in the synthesis of tricyclic compounds as insulin-like growth factor 1 receptor (IGF1R) inhibitors useful in the treatment of neoplastic diseases, inflammatory disorders, and immunomodulatory disorders.
參考文獻
Gregor, V.E.: U.S. Pat. Appl. Publ.В?USВ?20140228350В?A1В?20140814. Aug 14, 2014